Alternative Care Access

Take action and stay informed by becoming an AACPN member today

The issue

Federal healthcare programs were largely designed around conventional medical models that developed decades ago. While many traditional treatments remain essential, scientific research has increasingly explored complementary and alternative approaches that may improve outcomes for certain patients and conditions.

Coverage policies often lag behind emerging evidence. Patients may face significant out-of-pocket costs for therapies that are unavailable through their healthcare benefits despite growing scientific interest and demonstrated potential in specific clinical settings.

For veterans living with post-traumatic stress, patients managing chronic pain, seniors seeking non-pharmaceutical treatment options, or individuals recovering from trauma, limited coverage can create barriers to care and reduce treatment choices. The result is a healthcare system that may not fully reflect the range of therapies being evaluated by researchers, healthcare providers, and public health institutions.

The initiative

The American Alternative Care Policy Network envisions a healthcare system where coverage decisions are guided by evidence rather than tradition alone, where patients and healthcare providers have access to the full spectrum of scientifically supported treatment options, and where veterans, seniors, low-income families, trauma survivors, and other Americans can obtain the care that best meets their individual needs.

That is why the AACPN is advancing a federal policy initiative to expand VA, Medicare, and Medicaid coverage for alternative and integrative healthcare services supported by scientific research, helping veterans, trauma survivors, first responders, seniors, and other patients access the treatments that work best for them.

Millions of Americans rely on these programs for healthcare coverage, yet many treatments that patients increasingly seek—including acupuncture, nutritional therapies, psychedelic-assisted therapies under approved protocols, mindfulness-based interventions, and other integrative approaches—remain unavailable, inconsistently covered, or inaccessible due to outdated reimbursement policies.

AACPN believes healthcare decisions should be guided by science, patient outcomes, and informed choice. As emerging research continues to evaluate the effectiveness of alternative and integrative treatments for chronic pain, post-traumatic stress, depression, anxiety, substance-use disorders, and other conditions, federal healthcare programs should be prepared to modernize coverage policies when the evidence supports doing so.

The initiative seeks to ensure that veterans, seniors, low-income families, trauma survivors, first responders, and other patients have access to the full range of safe, effective, and evidence-based treatment options available within modern healthcare.

AACPN In Action

AACPN is working to advance federal policies that modernize healthcare coverage and improve access to evidence-based alternative care options.

The organization is:

• Educating policymakers on emerging research involving alternative and integrative therapies.

• Supporting continued clinical research and data collection.

• Engaging veterans, healthcare providers, patient advocates, and researchers.

• Monitoring federal agency actions affecting coverage policies.

• Promoting public awareness regarding access barriers and treatment options.

• Advocating for patient-centered, evidence-based healthcare reforms.

Through this effort, AACPN seeks to help ensure that federal healthcare programs evolve alongside scientific knowledge and continue serving the needs of the patients who depend on them.

Proposed Reforms

AACPN supports a structured, evidence-driven process for evaluating and expanding coverage of alternative and integrative healthcare services within the VA, Medicare, and Medicaid programs.

Potential reforms include:

• Establishing regular federal reviews of emerging clinical research.

• Creating transparent pathways for evaluating alternative therapies for coverage eligibility.

• Expanding reimbursement for treatments with demonstrated safety and effectiveness.

• Supporting pilot programs that evaluate innovative care models.

• Encouraging research partnerships involving veterans, trauma survivors, chronic pain patients, and other underserved populations.

• Modernizing federal reimbursement frameworks to better reflect advances in healthcare research.

Coverage decisions should remain grounded in scientific evidence, patient safety, clinical outcomes, and fiscal responsibility.

Areas of Focus

As scientific understanding evolves, AACPN believes federal healthcare programs should remain open to innovation while maintaining rigorous standards for safety and effectiveness. AACPN supports evaluating a broad range of alternative and integrative healthcare approaches through a consistent evidence-based framework.

Areas of focus include:

• Acupuncture

• Psychedelic-assisted therapies

• Ketamine-assisted psychotherapy

• Nutritional and lifestyle interventions

• Mindfulness-based therapies

• Biofeedback and neurofeedback

• Functional and integrative medicine approaches

• Non-opioid pain management strategies

• Emerging therapies supported by peer-reviewed research

Latest on the issue

Department of Health and Human Services and Department of Veterans Affairs announce partnership to advance psychedelic-assisted therapies for veterans

HHS & VA Announce Bold, Comprehensive Partnership to Advance Rapid-Acting Mental Health Treatments for Veterans

The U.S. Department of Health and Human Services and the Department of Veterans Affairs have announced a landmark partnership to accelerate research and implementation of rapid-acting mental health treatments for veterans, including psychedelic-assisted therapies. Read the official federal announcement below.

Rand: Nearly 5 Million U.S. Veterans Have Used Psilocybin Mushrooms, LSD or MDMA; Veterans' Policy Preferences Differ by Psychedelic Substance

Nearly 5 Million U.S. Veterans Have Used Psilocybin Mushrooms, LSD or MDMA; Veterans' Policy Preferences Differ by Psychedelic Substance

Gordon Op-Ed: CT can be a national leader in evidence-based healthcare innovation

Originally published in the Hartford Courant, this op-ed examines Connecticut's Public Act 26-108 and its implications for psychedelic-assisted therapy, evidence-based healthcare innovation, and patient access.